Suppr超能文献

创伤性脑损伤与帕金森病之间的生物学联系。

Biological links between traumatic brain injury and Parkinson's disease.

机构信息

Laboratory of Molecular Biology, VA New Jersey Health Care System, Research and Development (Mailstop 15), 385 Tremont Ave, East Orange, NJ, 07018, USA.

NeuroBehavioral Research Laboratory, VA New Jersey Health Care System, Research and Development (Mailstop 15), 385 Tremont Ave, East Orange, NJ, 07018, USA.

出版信息

Acta Neuropathol Commun. 2020 Apr 7;8(1):45. doi: 10.1186/s40478-020-00924-7.

Abstract

Parkinson's Disease (PD) is a progressive neurodegenerative disorder with no cure. Clinical presentation is characterized by postural instability, resting tremors, and gait problems that result from progressive loss of A9 dopaminergic neurons in the substantia nigra pars compacta. Traumatic brain injury (TBI) has been implicated as a risk factor for several neurodegenerative diseases, but the strongest evidence is linked to development of PD. Mild TBI (mTBI), is the most common and is defined by minimal, if any, loss of consciousness and the absence of significant observable damage to the brain tissue. mTBI is responsible for a 56% higher risk of developing PD in U.S. Veterans and the risk increases with severity of injury. While the mounting evidence from human studies suggests a link between TBI and PD, fundamental questions as to whether TBI nucleates PD pathology or accelerates PD pathology in vulnerable populations remains unanswered. Several promising lines of research point to inflammation, metabolic dysregulation, and protein accumulation as potential mechanisms through which TBI can initiate or accelerate PD. Amyloid precursor protein (APP), alpha synuclein (α-syn), hyper-phosphorylated Tau, and TAR DNA-binding protein 43 (TDP-43), are some of the most frequently reported proteins upregulated following a TBI and are also closely linked to PD. Recently, upregulation of Leucine Rich Repeat Kinase 2 (LRRK2), has been found in the brain of mice following a TBI. Subset of Rab proteins were identified as biological substrates of LRRK2, a protein also extensively linked to late onset PD. Inhibition of LRRK2 was found to be neuroprotective in PD and TBI models. The goal of this review is to survey current literature concerning the mechanistic overlap between TBI and PD with a particular focus on inflammation, metabolic dysregulation, and aforementioned proteins. This review will also cover the application of rodent TBI models to further our understanding of the relationship between TBI and PD.

摘要

帕金森病(PD)是一种无法治愈的进行性神经退行性疾病。临床特征为姿势不稳、静止性震颤和步态问题,这些问题是由于黑质致密部 A9 多巴胺能神经元进行性丧失所致。创伤性脑损伤(TBI)已被认为是几种神经退行性疾病的危险因素,但最强的证据与 PD 的发生有关。轻度 TBI(mTBI)最为常见,其定义为意识丧失最小或无,脑组织结构无明显可见损伤。mTBI 使美国退伍军人患 PD 的风险增加 56%,且损伤程度越重,风险越高。尽管来自人体研究的大量证据表明 TBI 与 PD 之间存在关联,但 TBI 是否引发 PD 病理学或在易患人群中加速 PD 病理学发展这一基本问题仍未得到解答。有几项有前景的研究表明,炎症、代谢失调和蛋白质积累可能是 TBI 引发或加速 PD 的潜在机制。淀粉样前体蛋白(APP)、α-突触核蛋白(α-syn)、过度磷酸化的 Tau 和 TAR DNA 结合蛋白 43(TDP-43)是 TBI 后最常报道的上调蛋白之一,也与 PD 密切相关。最近,研究发现 TBI 后小鼠大脑中 Leucine Rich Repeat Kinase 2(LRRK2)上调。一小部分 Rab 蛋白被鉴定为 LRRK2 的生物底物,LRRK2 也与迟发性 PD 广泛相关。LRRK2 抑制被发现对 PD 和 TBI 模型具有神经保护作用。本综述的目的是调查目前关于 TBI 和 PD 之间机制重叠的文献,特别关注炎症、代谢失调和上述蛋白。本综述还将涵盖啮齿动物 TBI 模型的应用,以进一步了解 TBI 和 PD 之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9efa/7137235/d58ae4f63f4d/40478_2020_924_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验